0001209191-20-062809.txt : 20201210
0001209191-20-062809.hdr.sgml : 20201210
20201210202444
ACCESSION NUMBER: 0001209191-20-062809
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201210
FILED AS OF DATE: 20201210
DATE AS OF CHANGE: 20201210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAY MARY ANN
CENTRAL INDEX KEY: 0001261974
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 201381955
MAIL ADDRESS:
STREET 1: 201 W 70TH ST, SUITE 23K
CITY: NEW YORK
STATE: NY
ZIP: 10023
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-10
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001261974
GRAY MARY ANN
215 FIRST STREET
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2020-12-10
4
M
0
967
0.00
A
5710
D
Restricted Stock Units
2020-12-10
4
M
0
967
0.00
D
2020-12-10
Common Stock
967
967
D
Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock.
The second out of three annual equal installments of restricted stock units vested on December 10, 2020.
/s/ David Tyronne Howton, as Attorney-in-Fact for Mary Ann Gray
2020-12-10